Skip to main content
. Author manuscript; available in PMC: 2015 Dec 10.
Published in final edited form as: J Neuroophthalmol. 2015 Mar;35(1):16–21. doi: 10.1097/WNO.0000000000000167

Table 2. Prevalence of eye movement abnormalities in patients with SCA.

SCA 1 (n = 56) (P) SCA 2 (n = 69) (P) SCA 3 (n = 119) (P) SCA 6 (n = 72) (P) P-Value Comparing All SCAs
Diplopia 24 (0.010) 18 (<0.001) 61 (<0.001) 43 (0.70) <0.001
GEN 44 (0.067) 13 (<0.001) 77 (<0.001) 78 (<0.001) <0.001
Hypermetric saccades 41 (0.67) 14 (<0.001) 50 (0.042) 51 (0.056) <0.001
Hypometric saccades 20 (0.13) 28 (0.81) 34 (0.038) 21 (0.19) 0.17
Slow saccades 47 (0.49) 80 (<0.001) 40 (0.31) 11 (<0.001) <0.001
Horizontal ophthalmoparesis 22 (0.63) 15 (0.22) 35 (<0.001) 2 (<0.001) <0.001
Vertical ophthalmoparesis 28 (0.67) 25 (0.46) 47 (<0.001) 6 (<0.001) <0.001
Abnormal smooth pursuit 45 (0.019) 37 (<0.001) 70 (0.023) 79 (0.001) <0.001
Square-wave jerks 11 (0.14) 5 (0.019) 23 (0.004) 17 (0.87) 0.012

Values are reported as % (P). The P-value is a comparison of that particular SCA against all other SCAs, as calculated with a χ2 test. The final column represents the P-value in comparing each individual SCA, as calculated with a 4-group χ2 test.

GEN, gaze-evoked nystagmus; SCA, spinocerebellar ataxia.